{"id":"NCT00300469","sponsor":"Abbott","briefTitle":"Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood","officialTitle":"A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of Fenofibric Acid and Atorvastatin Calcium Combination Therapy to Fenofibric Acid and Atorvastatin Calcium Monotherapy in Subjects With Mixed Dyslipidemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-03","primaryCompletion":"2007-02","completion":null,"firstPosted":"2006-03-09","resultsPosted":"2009-03-25","lastUpdate":"2009-06-03"},"enrollment":613,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Mixed Dyslipidemia","Coronary Heart Disease","Dyslipidemia"],"interventions":[{"type":"DRUG","name":"ABT-335","otherNames":[]},{"type":"DRUG","name":"Atorvastatin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"A","type":"ACTIVE_COMPARATOR"},{"label":"B","type":"ACTIVE_COMPARATOR"},{"label":"C","type":"PLACEBO_COMPARATOR"},{"label":"D","type":"PLACEBO_COMPARATOR"},{"label":"E","type":"PLACEBO_COMPARATOR"},{"label":"F","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to compare the safety and efficacy of fenofibric acid (ABT-335) + atorvastatin combination therapy with ABT-335 and atorvastatin monotherapy in subjects with multiple abnormal lipid levels in the blood.","primaryOutcome":{"measure":"Mean Percent Change in Triglycerides From Baseline to Final Visit","timeFrame":"Baseline to 12 Weeks (Final Visit)","effectByArm":[{"arm":"ABT-335 + 20 mg Atorvastatin","deltaMin":-45.6,"sd":3.36},{"arm":"ABT-335 + 40 mg Atorvastatin","deltaMin":-42.1,"sd":3.4},{"arm":"ABT-335","deltaMin":-29.6,"sd":3.35},{"arm":"20 mg Atorvastatin","deltaMin":-16.5,"sd":3.31},{"arm":"40 mg Atorvastatin","deltaMin":-23.2,"sd":3.35},{"arm":"80 mg Atorvastatin","deltaMin":-30.4,"sd":4.7}],"pValues":[{"comp":"OG000 vs OG003","p":"<0.001"},{"comp":"OG001 vs OG004","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["20573750","20136164","18783301"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1},"commonTop":["Headache","Diarrhea","Nausea","Myalgia","Upper respiratory tract infection"]}}